PPT-GOLD 2017 :an update for ICS/LABA role in COPD

management RIANA SARI 1 Agenda Definisi PPOK GOLD 2017 Etiologi patobiologi amp Patologi PPOK Diagnosis dan penilaian awal Tatalaksana PPOK GOLD 2017 Peranan kombinasi. . Dr Christopher Worsnop. Respiratory and Sleep Physician . Austin Hospital, Melbourne. . Conflict of interest – I’m an Aussie. OPTIMIZING . ASTHMA CONTROL. Barriers to achieving asthma control. (. long-acting. . muscarinic. . antagonist. . = . lang wirksame . Anticholinergica. ):. Aclidinium. Bretaris. ® . Genuair. ® 322 µg P . z.Inh. .. Eklira. ® . Genuair. ® 322 µg P . z.Inh. .. Glycopyrronium. Senior Officials. Objectives (1 of 2). Describe the Incident Command System (ICS).. Describe the various ways ICS can be applied.. Define the role of an Executive/Senior Official relative to the ICS. . San Francisco Asthma Network Forum 2016. Andi . Marmor. , MD, . MSEd. Professor of Pediatrics, . UCSF. Zuckerberg. San . Francisco General Hospital. Sept 21, 2016. Questions for this talk. How should asthma be classified at acute and preventive visits?. Introduction. Susceptibility to Exacerbation in COPD. Lung Function Impairment, COPD Hospitalizations and Mortality. Long-Term Natural History of COPD. Bronchoscopic Validation of the Significance of Sputum Purulence in Severe Exacerbations of COPD. Objectives of Treatment. GOLD 2018: Pharmacologic Treatment Recommendations. GOLD 2018: Pharmacologic Treatment Recommendations (. c. ont). GOLD 2018: Pharmacologic Treatment Recommendations in Groups C and D. Clinical Trial Evidence. Introduction . Therapeutic Recommendations . Therapeutic Recommendations in Groups B and D . Bronchodilators in Stable COPD. ICS in Stable COPD. COPD . Potential AEs of ICS Treatment. West Suffolk Integrated Formulary . Dr Linda Pearce. Respiratory Consultant Nurse. West Suffolk Hospital NHS Foundation Trust. Declaration . Linda Pearce has undertaken advisory board meetings, lectures and received support to attend educational meetings from. LABAForadil fomoterol discontinuedSerevent Diskus salmeterol 50 mcg 1 puff bidStriverdi Respimat olodaterol 25 mcg 2 puffs dailyLABA NebsBrovanaLAMAIncruse Elliptaumeclidinium 625 mcg all Ellipta devi bronchodilators include Combiventum Take with Respimatium Take with nebulizer These medications are long-acting Long-acting bronchodilators are used regularly to open the airways and keep them open Lo Updates inLaura Vaughan MDClinical Assistant Professor of MedicineStanford UniversityGINA slides used in this presentation are reproduced with permissionNo financial disclosuresSerious Consequences98 80 predicted and sometimes but not always Stage II Moderate COPD Worsening airflow limitation FEVbreath typically developing during exertion This is the stage at which patients typically seek medical Summary of key changes . Respiratory Franchise. ZINC code: . GLRESP/COPD/0233 . Date of preparation: December 2016. GOLD 2017 includes major revisions in key areas. Key areas of major revision:. Definition of COPD. Chapter . 17: Respiratory conditions. 1. . [Insert name of presenter/unit here]. [Insert date of presentation here]. 2. . EVIDENCE. Please access the National Essential Medicines List Committee (NEMLC) report for detailed evidence (including rationale, references and costings) informing decision-making on medicine addition, amendments and deletions:.